ABSTRACT
level (Gettys et al., 1994a; Yang and Lanier, 1999; Cordeaux et al., 2000; Wenzel-Seifert and Seifert, 2000; Akam et al., 2001 ), the precise nature of G proteins activated by 5-HT 2C receptors remains to be identified.
In fact, although 5-HT 2C receptors are "classically" considered to couple to Gq, only a few studies have directly demonstrated this. For example, stimulation of [
35 S]GTP␥S binding was observed in membranes of Sf9 insect cells expressing high levels of 5-HT 2C receptors reconstituted with exogenous Gq proteins (Hartman and Northup, 1996) . More recently, cell-permeable peptides mimicking the C-terminal component of Gq were shown to block activation of native 5-HT 2C receptors in the choroid plexus (Chang et al., 2000) . In addition to Gq, when using pertussis toxin (PTX), which uncouples GPCR receptors from Gi/o protein subtypes, it has been shown that 5-HT 2C receptors interact with PTX-sensitive Gi/o proteins controlling 1) DNA synthesis and proliferation in NIH-3T3 cells (Westphal and Sanders-Bush, 1996) , 2) adenylyl cyclase activity in an AV12 cell line (Lucaites et al., 1996) , and 3) membrane currents in Xenopus laevis oocytes (Quick et al., 1994) . Moreover, as with X. laevis oocytes, direct coupling of 5-HT 2C receptors to Gi 1 and Go was shown by an antisense strategy (Chen et al., 1994; Quick et al., 1994) . Finally, in human embryonic kidney (HEK) 293 cells expressing high levels of 5-HT 2C receptors, 5-HT was found to stimulate [
35 S]GTP␥S binding to Gi proteins (Alberts et al., 1999) .
In light of the above observations, the goal of the present study was to characterize the coupling of 5-HT 2C receptors to PTX-insensitive compared with PTX-sensitive G proteins in CHO cell membranes expressing a high level of the VSV (edited) isoform of human 5-HT 2C (h5-HT 2C ) receptors, which is preferentially expressed in the central nervous system (Herrick-Davis et al., 1999; Wang et al., 2000) . In addition to PTX, selective antibodies directed against different G protein subtypes can be used to identify their roles, for example, in immunoprecipitation assays of [ 35 S]GTP␥S labeled-G proteins and by uncoupling GPCRs from their respective G proteins (Lledo et al., 1992; Izenwasser and Cô té , 1995; Alberts et al., 1999; NewmanTancredi et al., 1999) . However, such techniques are time consuming. Thus, as originally described by DeLapp et al. (1999) , we used an antibody capture assay together with a detection technique employing anti-IgG-coated scintillation proximity assay (SPA) beads. This technique permitted measurement of the stimulation of Gq/11 and Gi 3 proteins in response to h5-HT 2C receptor activation induced by different agonists, such as 2(S)-1-(6-chloro-5-fluoro-1H-indol-1-yl)-2-propanamine fumarate (Ro600175) and lisuride, as well as the previously described hallucinogenic compounds LSD and 1-2,5-dimethoxy-4-iodophenyl-2-aminopropane (DOI) (Glennon, 1996) .
Differential coupling of GPCRs to distinct G proteins is known to be influenced by the presence of receptor reserve (Brink et al., 2000; Cordeaux et al, 2000) , and we have previously shown that h5-HT 2C receptors display a substantial receptor reserve for activation of PLC (Cussac et al., 2002) . We therefore examined the influence of receptor reserve at h5-HT 2C receptors on activation of Gq/11 and Gi 3 and agonist-directed trafficking.
Materials and Methods
Membrane Preparation of CHO-h5-HT 2C Cells. CHO cells stably expressing ϳ20 pmol mg Ϫ1 of edited h5-HT 2C receptors (VSV isoform) were obtained from Euroscreen (Brussels, Belgium) and grown in adherent culture in 225-cm 2 flasks with UltraCHO medium (BioWhittaker Europe, Verviers, Belgium) containing sodium pyruvate (1 mM), dialyzed fetal calf serum (0.1%), and geneticin (400 g/ml). Treatment of cells by pertussis toxin (Sigma-Aldrich, S. Quentin Fallavier, France) was performed overnight at 100 ng/ml. At confluence, cells were washed twice with buffer A containing 20 mM HEPES and 150 mM NaCl, pH 7.4. Cells were harvested from adherent culture and homogenized using a Kinematica Polytron homogenizer (20 s; Basel, Switzerland) in buffer A. The suspension was then centrifuged twice at 20,000g for 20 min at 4°C. The pellet was resuspended in buffer A, and an aliquot (ϳ20 mg of protein per ml) was stored at Ϫ80°C until assay.
Competition Binding Assays. Binding affinity at h5-HT 2C receptors was determined essentially as described previously (Cussac et al., 2002) by competition binding with [
3 H]mesulergine (1 nM; Amersham Biosciences Inc., Saclay, France) in a buffer containing HEPES (20 mM), pH 7.7, EDTA (2 mM), and ascorbic acid (0.1% w/v). Incubations lasted 2 h at 22°C, and nonspecific binding was defined by 5-HT (10 M). Isotherms were analyzed by nonlinear regression to yield IC 50 values. Inhibition constants (K i values) were derived from IC 50 values according to Lazareno and Birdsall (1993) .
Measurement of Agonist Efficacy and Antagonist Potency at h5-HT 2C Receptors. Receptor-linked G protein activation by agonists at h5-HT 2C receptors was determined by measuring the stimulation of [
35 S]GTP␥S (1332 Ci/mmol; PerkinElmer Life Sciences, Paris, France) binding. CHO-h5-HT 2C membranes (ϳ20-30 g per well) were preincubated 30 min with agonists and antagonists in a buffer B containing 20 mM HEPES, pH 7.4, 0.1 M GDP, 50 mM MgCl 2 , and 150 mM NaCl, and reaction was started with 0.2 nM [ 35 S]GTP␥S in a final volume of 200 l in 96-well plates for 60 min at room temperature. Experiments were terminated by rapid filtration through Unifilter-96 GF/B filters (PerkinElmer) using a Filtermate harvester (PerkinElmer Life Sciences, Boston, MA). Radioactivity retained on the filters was determined by liquid scintillation counting using a TopCount microplate scintillation counter (PerkinElmer Life Sciences). Agonist efficacy is expressed relative to 5-HT, which was tested at a maximal concentration in each experiment. Thus, basal binding (which includes both nonspecific radioactivity detection and endogenous guanine nucleotide turnover) is defined as 0%, whereas 5-HT-stimulated [
35 S]GTP␥S binding is defined as 100%. All data are expressed as mean Ϯ S.E.M. of at least three independent determinations.
Characterization of Antibodies Used in SPAs. To verify the specificity of the antibodies used in the SPA procedure, 25 ng of purified recombinant rat G␣o, G␣i 1 , G␣i 2 , G␣i 3 , G␣s, G␣q and G␣13 (Merck Eurolab S.A., Fontenay sous Bois, France) were loaded on 10% polyacrylamide gel and transferred onto nitrocellulose. Immunoblotting of G␣ subunits was performed using the polyclonal antiG␣q/␣11 (C19) from Santa Cruz Biotechnology (Santa Cruz, CA) (0.4 g/ml) and the monoclonal antibody anti-G␣i 1 from BIOMOL Research Laboratories (Plymouth Meeting, PA) (1 g/ml), followed by enhanced chemiluminescence detection with horseradish peroxidase as secondary antibody (1/6000) (Amersham Biosciences Inc.).
Scintillation Proximity Assays. Specific activation of different subtypes of G proteins was determined using SPAs essentially as described by DeLapp et al. (1999) . [
35 S]GTP␥S binding was performed in the same conditions described above but in 96-well optiplates (PerkinElmer Life Sciences). At the end of the incubation period, 20 l of Nonidet P-40 (0.27% final concentration) was added to each well, and the plates were incubated with gentle agitation for 30 min. Antibodies specific for the G protein ␣-subunit of interest were then added to each well in a volume of 10 l before 30 min of additional incubation period. The antibodies employed were the poly- clonal anti-G␣q/␣11 (1.74 g/ml final dilution) and the monoclonal antibody anti-G␣i 1 (0.87 g/ml final dilution). SPA beads coated with secondary anti-rabbit or anti-mouse antibodies from Amersham Biosciences UK, Ltd. (Little Chalfont, Buckinghamshire, UK) were added in a volume of 50 l at a dilution indicated by the manufacturer, and the plates were incubated for 3 h with gentle agitation. The plates were then centrifuged (10 min at 1300g), and radioactivity was detected on a TopCount microplate scintillation counter. Agonist efficacy is expressed relative to that of 5-HT, which was tested at a maximally effective concentration in each experiment (0.1 and 1 M at Gq/11 and Gi 1,3 , respectively). All data are expressed as mean Ϯ S.E.M. of at least three independent determinations. 5-HT 2C Receptor Alkylation with EEDQ. CHO-h5-HT 2C membranes were treated in buffer B with the alkylating agent, EEDQ, at a final concentration of 100 M for 60 and 90 min at 30°C followed by SPA as described above. The percentage of maximal response as a function of the receptor occupancy (receptor reserve) was determined as described previously (Cussac et al., 2002 
where L is the concentration of agonist. The curve is fitted by a rectangular hyperbola. All data are expressed as means Ϯ S.E. of the mean of three independent determinations performed in triplicate. The level of h5-HT 2C receptor expression after EEDQ treatment was determined by saturation experiments with [ 3 H]mesulergine in parallel with SPA using the same membrane preparation. Protein concentration was determined colorimetrically using a bicinchoninic acid assay kit (Sigma-Aldrich).
Data Analysis. Isotherms were analyzed by nonlinear regression, using GraphPad Prism (GraphPad Software Inc., San Diego, CA) to yield EC 50 and IC 50 values. K B values of antagonists for inhibition of (Table 1) . Moreover, the potencies of 5-HT, Ro600175, and DOI were increased by 2-to 5-fold by PTX cell treatment compared with untreated cells, whereas the potencies of LSD and lisuride were unaffected (Table 1) .
Specificity of Antibodies: Scintillation Proximity Assays Coupled to [
35 S]GTP␥S Binding. To address the issue of the precise nature of activated G protein in CHO-5-HT 2C cells, we used two antibodies raised against G␣q/11 or G␣i 1 subunits. Fig. 2 shows that the monoclonal antibody anti-G␣i 1 did indeed recognize G␣i 1 but that it also crossreacted with the G␣i 3 subunit. However, this antibody did not bind with other G␣ subunits of the Gi family (i.e., G␣i 2 and G␣o) (Fig. 2) . Previous studies of immunoreactive G␣ subunits in CHO-K1 cells have detected G␣i 2 and G␣i 3 together with low levels of G␣o, whereas G␣i 1 is undetectable (Dell'Acqua et al., 1993; Raymond et al., 1993; Gettys et al., 1994b) . Thus, we can conclude that the anti-G␣i 1,3 antibody recognized G␣i 3 in CHO cells. The polyclonal antibodies against G␣q/11 have already been well characterized by Western blot and immunoprecipitation assays (DeLapp et al., 1999; Mirotznik et al., 2000; Akam et al., 2001) . Indeed, in our hands, the polyclonal anti-G␣q/␣11 antibody recognized the G␣q subunit with no affinity for other G␣ subunits tested (Fig. 2) . Thus, anti-G␣i 3 and anti-G␣q/11 antibodies were used in antibody-capture assays with SPA detection. 5-HT and Ro600175 induced robust signals in stimulating [ 35 S]GTP␥S binding at both Gq/11 (typically ϳ1.7 to 2.2-fold; Fig. 3A ) and Gi 3 (ϳ1.6 to 1.9-fold; Fig. 3B ) in CHO-h5-HT 2C cells. The stimulation of Gq/11 and Gi 3 induced by 5-HT and Ro600175 was blocked by SB242,084, a selective h5-HT 2C antagonist (Fig. 3, A Table 2 ).
Fig. 2.
Immunodetection of G␣ subunits. Purified G␣o, G␣i 1 , G␣i 2 , G␣i 3 , G␣s, G␣q, and G␣13 subunits were separated on a gel and submitted to immunodetection using polyclonal antibody anti-G␣q/␣11 (〈) and the monoclonal antibody anti-G␣i 1 (B) as described under Materials and Methods. (Table 1 ). In contrast, Ro600175 and DOI exhibited lower efficacy than 5-HT at Gi 3 protein (P Ͻ0.05, unpaired t test). LSD exhibited partial agonism (ϳ30%) compared with 5-HT, lisuride being inactive at Gi 3 proteins (Fig. 4; Table 2 ). Agonist potency for stimulation of Gi 3 was about 6-to 8-fold less than for Gq/11 activation, except for LSD, which exhibited similar potency for activation of both G proteins ( (Fig. 5) . Antagonist potencies of lisuride at Gq/11 and Gi 3 were 7.76 Ϯ 0.10 and 7.25 Ϯ 0.06, respectively, and LSD exhibited a pK B of 7.47 Ϯ 0.05 at Gi 3 (Fig. 5) .
h5-HT 2C Receptor Alkylation with EEDQ. EEDQ treatment of membranes (100 M, 30°C) time dependently decreased the density of h5-HT 2C sites by 3.4-and 7.4-fold after 60 and 90 min of treatment, respectively, as determined by [ 3 H]mesulergine saturation binding (Fig. 6 ). The K D value for [
3 H]mesulergine binding in control membranes (1.38 Ϯ 0.13 nM) was unchanged by EEDQ treatment (1.37 Ϯ 0.08 nM and 1.59 Ϯ 0.15 nM for 60 and 90 min, respectively).
Influence of h5-HT 2C Receptor Alkylation with EEDQ On Gq/11 and Gi 3 Activation. The concentrationresponse curves of 5-HT-, Ro600175-, and DOI-mediated [ 35 S]GTP␥S binding to Gq/11 were progressively shifted to the right by treatment of CHO-h5-HT 2C cells with EEDQ without a significant alteration in their relative efficacies, suggesting substantial receptor reserve ( Fig. 7; Table 3 ). In contrast, LSD behaved as a partial agonist after EEDQ treatment, stimulating [
35 S]GTP␥S binding to Gq/11 by 38% (EEDQ, 90 min) compared with 5-HT (100%), without modification of its potency ( Fig. 7; Table 3 ). The K A value for LSD at Gq/11 determined by Furchgott analysis was 12.8 Ϯ 3.6 nM. The derived occupancy/response yielded a linear plot with a half-maximal response to LSD at 48 Ϯ 4.5% occupation of h5-HT 2C binding sites, demonstrating the absence of receptor reserve with this ligand for Gq/11 activation (Fig. 8) .
In the case of Gi 3 activation, EEDQ treatment reduced both the potency of [
35 S]GTP␥S binding by agonists as well as relative efficacies ( Fig. 7; Table 3) , suggesting a lower level of receptor reserve for Gi 3 activation than Gq/11. The partial agonist, LSD, failed to activate Gi 3 after the diminution of functional h5-HT 2C receptors by EEDQ treatment (Fig. 7) . The K A values for 5-HT (248 Ϯ 102 nM), Ro600175 (110 Ϯ 21 nM), and DOI (249 Ϯ 99 nM) determined by Furchgott anal- Table 2 . Agonist efficacies at Gq/11 and Gi 3 proteins were determined by ͓ 35 S͔GTP␥ S binding coupled to a scintillation proximity assay. Agonist efficacies are expressed relative to that of 5-HT, which was tested at a maximally effective concentration in each experiment (0.1 and 1 M at Gq/11 and Gi 3 , respectively) and are means Ϯ S.E.M. of at least three independent experiments. pK i values were determined as described under Materials and Methods and are means Ϯ S.E.M. of at least three independent experiments. 
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at ASPET Journals on October 29, 2017 molpharm.aspetjournals.org ysis yielded hyperbolic curves, with the half-maximal response for Gi 3 activation being observed at h5-HT 2C occupancies of 13.0 Ϯ 3.7% for 5-HT, 21.6 Ϯ 2.7% for Ro600175, and 33.7 Ϯ 2.1% for DOI (Fig. 8) . The receptor occupancy by DOI required to yield half-maximal Gi 3 activation was significantly greater (P Ͻ0.05, unpaired t test) than for 5-HT or Ro600175.
Discussion
The key findings of the present study are 1) the detection by [
35 S]GTP␥S binding of 5-HT 2C receptor-mediated activation of PTX-sensitive and -insensitive G proteins in CHO cell membranes, 2) the demonstration by an antibody capture/ SPA detection strategy that 5-HT 2C receptors coupled more efficiently to Gq/11 than to Gi 3 , and 3) as revealed by receptor alkylation, this difference reflects a high versus low level of receptor reserve for 5-HT 2C receptors coupled to Gq/11 and Gi 3 , respectively.
[ binding to G␣ 12 and G␣ 13 proteins, which can also couple to 5-HT 2C receptors (Berg et al., 1999; Price et al., 2001) , cannot be excluded. Thus, although direct labeling of Gq by [ 35 S]GTP␥S binding is difficult to detect, owing to low GTPturnover rates (Smrcka et al., 1991) , 5-HT 2C receptors are able to activate [ 35 S]GTP␥S binding to Gq/11 proteins in CHO cells (present study) as well as in nonmammalian (insect Sf9) cells (Hartman and Northup, 1996) . Interestingly, because PTX did not affect the potency or efficacy of LSD and lisuride, we may surmise that these ligands mainly activated PTX-insensitive G proteins, probably Gq/11, in CHO-h5-HT 2C cell membranes. Lisuride has previously been shown to exhibit antagonist properties at 5-HT 2C receptors coupled to PLC in choroid plexus cells (Burris et al., 1991) , whereas lisuride and LSD acted as weak partial agonists in NIH-3T3 cells (Egan et al., 1998) . In the Table 3 . f, control; OE, EEDQ 60 min; ࡗ, EEDQ 90 min.
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at ASPET Journals on October 29, 2017 molpharm.aspetjournals.org present system, LSD behaved as a full agonist for stimulation of PTX-insensitive G proteins, in accordance with a study of inositol phosphate accumulation in HEK 293 cells expressing a high level of 5-HT 2C receptors (Fitzgerald et al., 1999) . However, the efficacy of lisuride represented about half that of LSD, in line with previous reports (Egan et al., 1998; Fitzgerald et al., 1999) . Together with the finding that PTX treatment enhanced the potency of 5-HT, Ro600175, and DOI, these results suggest that h5-HT 2C receptor activation preferentially engaged PTX-insensitive compared with PTXsensitive G proteins.
5-HT 2C Receptors Are Coupled to Gq/11 and Gi 3 in CHO Cells: SPA Approach. Antibody capture/SPA detection using specific antibodies (see Results) allowed direct measurement of Gq/11 and Gi 3 activation with a robust signal-to-noise ratio even after extensive receptor inactivation by irreversible alkylation (see below). This SPA approach underpinned the above-discussed results concerning the in- (Giles et al., 1996) .
Although the hallucinogenic compound LSD (Glennon, 1996) did not exhibit different potencies in stimulating Gq/11 and Gi 3 , it behaved as a full agonist at the former and as a weak partial agonist at the latter. Furthermore, like lisuride, LSD antagonized 5-HT-induced stimulation of Gi 3 (Fig. 5) . Previous studies in HEK 293 cells have likewise shown that LSD is more efficacious at Gq (inositol generation) than at Gi/o ([ 35 S]GTP␥S binding) (Alberts et al., 1999) . However, although in the present study, 5-HT, RO600175, and DOI more potently activated Gq/11 than Gi 3 , the potency of 5-HT was similar at these G protein subtypes in the report of Alberts et al (1999) . This distinction may be related to the use of a different isoform of h5-HT 2C receptor, because it has been shown that editing of 5-HT 2C receptors affects both PLC activation as well as G protein coupling (Backstrom et al., 1999; Berg et al., 2001; Price et al., 2001 ). The present differences in the actions of agonists at Gq/11 compared with Gi 3 may influence trafficking of 5-HT 2C receptor signaling at the effector level, as has been reported for stimulation of PLC and PLA 2 as well as cGMP production (Berg et al., 1998 (Berg et al., , 2001 Miller et al., 2000) . Importantly, the application of antibody capture/SPA detection methodology to G proteins circumvents indirect effects, which may complicate interpretation of changes in signals downstream of G proteins. This include effector crosstalk (PLC and PLA 2 sensitivity to ␤␥ subunits and Ca 2ϩ , respectively), effector/receptor desensitization by protein kinase C (Cockcroft and Thomas, 1992) , and direct actions of ligands at signals downstream to, or in parallel with, G proteins (Bockaert and Pin, 1999) .
Receptor Reserve of h5-HT 2C Receptor VSV Isoform Coupled to Gq/11 and Gi 3 . Recently, Brink et al (2000) reported that agonist-directed trafficking at human ␣ 2A -adrenoceptors is dependent on the level of receptor expression and, specifically, the presence of receptor reserve. Indeed, receptor number and receptor/G protein stoichiometry, as well as the specific identity of the G proteins activated, probably influence drug efficacies for activation of differing signaling cascades. For h5-HT 2C receptors, no receptor reserve for PLC activation was demonstrated at edited VSV and nonedited INI isoforms expressed in NIH-3T3 cells, despite the relatively high expression levels (ϳ5 pmol/mg) (Burns et al., 1997) . In contrast, the VNV isoform of h5-HT 2C receptors expressed in HEK 293 exhibited receptor reserve for PLC activation, LSD behaving as a full agonist with increasing receptor number (Fitzgerald et al., 1999) . Although these observations may reflect differential coupling between h5-HT 2C receptor isoforms, variations in receptor/G protein stoichiometry are likely to be of major importance. Correspondingly, we investigated the influence of reducing receptor number (and therefore receptor/G protein stoichiometry) with the alkylating agent EEDQ.
In corroboration of our previous observations of the effect of EEDQ on h5-HT 2C (VSV) receptor-mediated PLC activity (Cussac et al., 2002) , we demonstrate herein that a high degree of receptor reserve exists for Gq/11 stimulation. Indeed, the potencies but not efficacies of 5-HT, Ro600175, and DOI for Gq/11 activation were reduced by EEDQ pretreatment, although the number of h5-HT 2C receptors was diminished 7-fold (Fig. 6) . In contrast, LSD exhibited partial agonist properties upon reduction of the density of functional h5-HT 2C receptors. Accordingly, the occupancy/response plot of LSD for Gq/11 activation was linear, implying an absence of receptor reserve (Fig. 8) , consistent with its partial agonist properties in other systems (Egan et al., 1998; Fitzgerald et al., 1999) .
In contrast to Gq/11 activation, EEDQ markedly affected the efficacy of all agonists for h5-HT 2C receptor-mediated Gi 3 activation. Indeed, although hyperbolic occupancy/response plots were observed for 5-HT and Ro600175, the degree of receptor reserve was less than for activation of Gq/11. Moreover, in accordance with its partial agonist properties for Gi activation (Alberts et al., 1999) , PLC activation (Fitzgerald et al., 1999) , and Ca 2ϩ mobilization (Porter et al., 1999) , DOI revealed a lower receptor reserve than 5-HT (Fig. 8) . Thus, in the present system, potential agonist-directed trafficking by LSD and DOI must take into account the large receptor reserve for efficacious agonists, such as 5-HT and Ro600175. Thus, after 90-min EEDQ treatment of CHO-h5-HT 2C membranes, pEC 50 values for agonist stimulation of Gq/11 were similar to pEC 50 values observed for Gi 3 under control conditions. It is interesting to note that, under these conditions of "pEC 50 equivalence", the (partial agonist) efficacy of LSD and DOI at Gq/11 approached that of Gi 3 . It may be concluded that the markedly higher efficacy of the partial agonists, DOI and LSD, at Gq/11 compared with Gi 3 (observed in the absence of EEDQ) is associated with the more efficient coupling of h5-HT 2C receptors to Gq/11 versus Gi 3 . Hence, caution should be exercised when differentiating potential agonist-directed trafficking from "strength-of-signal" mechanisms (for a review see Kenakin, 1995) . In fact, agonistdirected trafficking implies a reordering of relative drug efficacies upon comparison of two G proteins (or, more generally, two effector pathways). In contrast, strength-ofsignal mechanisms reflect receptor reserve, receptor/G protein stoichiometry, nature of expressed G proteins, etc. Thus, a strength-of-signal scheme, as well as agonist-directed trafficking, could account for the present observations. LSD and DOI (and lisuride) express their "agonist-directed trafficking" properties only under certain conditions of receptor reserve and/or receptor/G protein stoichiometry. A similar conclusion was reached by Brink et al. (2000) for ␣ 2A -adrenoceptor coupling to adenylyl cyclase via Gi and Gs. Indeed, agonist-directed trafficking by L-isoproterenol to Gs activation versus Gi was only observed under conditions where the full agonist, 5-bromo-N-(4,5-dihydro-1H-imidazol-2-yl)-6-quinoxalinamine, exhibited similar potency for activation of both G proteins.
These observations raise the question of whether receptor reserve exists for Gq/11 and/or Gi 3 in physiological systems. In this context, it should be noted that coupling to Gi 3 was observed herein even after extensive EEDQ treatment, reducing receptor expression to about 2 pmol/mg. In rat choroid plexus neurons, 5-HT 2C expression levels (for a mixture of cell types) is also in the picomole(s) per milligram range (Yagaloff and Hartig, 1985) , suggesting that the present data in CHO cells are relevant to central populations of 5-HT 2C receptors. Nevertheless, further investigation is necessary to clarify the pertinence of the present data to other edited isoforms of h5-HT 2C receptors. LSD, for example, did not stimulate PLC activity at the VGV isoform of 5-HT 2C receptors (Backstrom et al., 1999; Berg et al., 2001) . Applying the present antibody capture/SPA detection strategy to other h5-HT 2C isoforms would enable this issue to be rapidly evaluated. Finally, it would be interesting to evaluate whether functional properties of LSD, DOI, and other agonists at h5-HT 2C receptors may reflect their differential recruitment of specific G protein subtypes. Activation of 5-HT 2A receptors, which couple to Gq/11 and PTX-sensitive G proteins (Kurrasch and Nichols, 2001) , is associated with hallucinations, delusions, and many other effects (Glennon, 1996; Nelson et al., 1999) . It would therefore be interesting to determine, in analogy with h5-HT 2C receptors, whether LSD and DOI exhibit differential G protein activation at h5-HT 2A receptors.
Conclusions
To summarize, the present study demonstrates that h5-HT 2C receptors (VSV isoform) couple to both Gq/11 and Gi 3 in CHO cells and that these G protein subtypes are recruited in an agonist-and receptor reserve-dependent manner. The differential influence of agonists on G protein coupling at h5-HT 2C receptors may well be relevant to their functional profiles in vivo. It would be of interest to extend these data in characterizing the significance of receptor reserve, receptor/G protein stoichiometry, and G protein subtypes at other isoforms of h5-HT 2C receptors as well as other classes of GPCR that couple to multiple intracellular signals.
